Nanostructured Lipid Carrier-Based Delivery of Pioglitazone for Treatment of Type 2 Diabetes

• Päätekijät: Umair Ilyas (Tekijä), Muhammad Asif (Tekijä), Minglian Wang (Tekijä), Reem Altaf (Tekijä), Hajra Zafar (Tekijä), Mirza Muhammad Faran Ashraf Baig (Tekijä), Ana Cláudia Paiva-Santos (Tekijä), Muhammad Abbas (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Pioglitazone (PGZ) is utilized as a therapeutic agent in the management of (type 2) diabetes to control blood glucose levels. The existing research work was intended to make and optimize PGZ-containing NLCs (nanostructured lipid carriers). The fabricated nanostructured lipid carrier preparation was...